We are live on
!
Find out more
RL
Ruffer LLP Portfolio holdings
AUM
$2.44B
1-Year Est. Return
44.75%
This Fund
S&P 500
This Quarter
Est. Return
+18.22%
1 Year Est. Return
+44.75%
3 Year Est. Return
+105.9%
5 Year Est. Return
+158.64%
10 Year Est. Return
+642.68%
AUM
$3.43B
AUM Growth
-$91.6M
(-2.6%)
Cap. Flow
-$572M
Cap. Flow
% of AUM
-16.67%
Top 10 Holdings %
Top 10 Hldgs %
62.86%
Holding
98
New
5
Increased
18
Reduced
40
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$294M |
| 2 |
Freeport-McMoran
FCX
|
+$172M |
| 3 |
eHealth
EHTH
|
+$76.5M |
| 4 |
Dow Inc
DOW
|
+$55.4M |
| 5 |
General Motors
GM
|
+$38.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$318M |
| 2 |
Amgen
AMGN
|
+$218M |
| 3 |
Walt Disney
DIS
|
+$133M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$111M |
| 5 |
Cigna
CI
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 32.47% |
| 2 | Healthcare | 23.38% |
| 3 | Communication Services | 13.54% |
| 4 | Energy | 13.02% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Walmart Inc
WMT
$871B
| $277K | 0.01% |
6,984
-1,200
| -15% | -$47.7K |
|
77
Arch Capital
ACGL
$36.1B
| $258K | 0.01% |
6,000
| – | – |
|
|
RDS.B
78
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $246K | 0.01% |
4,100
-1,100
| -21% | -$64.8K |
|
|
PLG
79
Platinum Group Metals
PLG
$164M
| $236K | 0.01% |
138,421
| – | – |
|
80
Mattel
MAT
$4.17B
| $136K | ﹤0.01% |
10,000
| – | – |
|
|
AUY
81
DELISTED
Yamana Gold, Inc.
AUY
| $90K | ﹤0.01% |
22,763
-2,350
| -9% | -$8.25K |
|
82
Biogen
BIIB
$29.9B
| – | – |
-3,500
| Closed | -$815K |
|
83
Berkshire Hathaway Class B
BRK.B
$1.07T
| – | – |
-2,000
| Closed | -$416K |
|
84
Coeur Mining
CDE
$15.6B
| – | – |
-1,343,063
| Closed | -$6.44M |
|
85
Charter Communications
CHTR
$14.7B
| – | – |
-1,750
| Closed | -$721K |
|
86
Cleveland-Cliffs
CLF
$6.81B
| – | – |
-11,228,651
| Closed | -$81.1M |
|
87
Fox Class A
FOXA
$23.2B
| – | – |
-106,984
| Closed | -$3.37M |
|
88
Imperial Oil
IMO
$62.1B
| – | – |
-43,915
| Closed | -$1.15M |
|
89
Lennar Class A
LEN
$20.4B
| – | – |
-7,026
| Closed | -$380K |
|
90
Pan American Silver
PAAS
$18.6B
| – | – |
-1,463,688
| Closed | -$22.9M |
|
91
Patterson-UTI
PTEN
$3.87B
| – | – |
-300,000
| Closed | -$2.56M |
|
92
Sibanye-Stillwater
SBSW
$5.92B
| – | – |
-150,000
| Closed | -$811K |
|
93
Spectrum Brands
SPB
$2.04B
| – | – |
-34,071
| Closed | -$1.8M |
|
94
Tidewater
TDW
$3.91B
| – | – |
-10,000
| Closed | -$151K |
|
95
UBS Group
UBS
$170B
| – | – |
-14,354
| Closed | -$163K |
|
96
Ultrapar
UGP
$6.87B
| – | – |
-18,452
| Closed | -$82K |
|
|
OSB
97
DELISTED
Norbord Inc.
OSB
| – | – |
-11,500
| Closed | -$276K |
|
|
CELG
98
DELISTED
Celgene Corp
CELG
| – | – |
-3,204,402
| Closed | -$318M |
|
Similar funds
QT
TMC
GWM
KFA
BW
M
BBA
PUI
Ruffer LLP's Q4 2019 Portfolio in Review
As of Q4 2019, Ruffer LLP held 98 positions worth $3.43B, down 2.6% from $3.52B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Ruffer LLP withdrew a net $572M in Q4 2019, closing 17 positions and reducing 40 holdings. Its most notable exit was Celgene Corp, an estimated $318M position sold in full.
By sector, the portfolio is most concentrated in Materials at 32% of assets, up from 24% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Ruffer LLP opened a new position in eHealth worth $94.7M.
- Ruffer LLP's largest Q4 2019 buy was eHealth: 985,957 shares worth $94.7M.
- Ruffer LLP added most to Bristol-Myers Squibb in Q4 2019, an estimated $294M increase.
- Ruffer LLP's biggest Q4 2019 reduction was Amgen, cutting an estimated $218M.
- Ruffer LLP fully exited Celgene Corp in Q4 2019, selling an estimated $318M.
- Ruffer LLP's ten largest holdings make up 63% of its $3.43B portfolio in Q4 2019.
- Ruffer LLP opened 5 new positions and closed 17 in Q4 2019.
- Ruffer LLP's portfolio value fell 2.6% quarter-over-quarter to $3.43B.
Based on Ruffer LLP's 13F filing for Q4 2019, filed 6 Feb 2020.